Darlisha A Williams

发表

HuA and Tristetraprolin Are Induced following T Cell Activation and Display Distinct but Overlapping RNA Binding Specificities*

A. Raghavan, P. Bohjanen, Rachel L. Robison, 2001, The Journal of Biological Chemistry.

Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis

D. Boulware, Darlisha A Williams, M. Nicol, 2019, Journal of Pharmacokinetics and Pharmacodynamics.

Tristetraprolin recruits functional mRNA decay complexes to ARE sequences

C. Reilly, Rachel L. Ogilvie, P. Bohjanen, 2007, Journal of cellular biochemistry.

Management of amphotericin-induced phlebitis among HIV patients with cryptococcal meningitis in a resource-limited setting: a prospective cohort study

D. Boulware, K. H. Hullsiek, Darlisha A Williams, 2019, BMC Infectious Diseases.

Symptoms of COVID-19 Outpatients in the United States

S. Lofgren, D. Boulware, K. H. Hullsiek, 2020, Open forum infectious diseases.

Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study

D. Boulware, A. Elliott, F. Cresswell, 2020, The Lancet. Infectious diseases.

Can improved diagnostics reduce mortality from Tuberculous meningitis? Findings from a 6.5-year cohort in Uganda.

D. Boulware, A. Elliott, F. Cresswell, 2018, Wellcome open research.

The conundrum of clinical trials and standard of care in sub-Saharan Africa – the research nurse perspective

D. Boulware, Darlisha A Williams, M. Abassi, 2019, Journal of research in nursing : JRN.

Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19

S. Lofgren, D. Boulware, K. H. Hullsiek, 2020, Open forum infectious diseases.

Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART Initiation

D. Boulware, K. H. Hullsiek, Darlisha A Williams, 2018, Open forum infectious diseases.

Improved Diagnostic Sensitivity for TB Meningitis with Xpert MTB/Rif of centrifuged CSF: a prospective study

Reuben., D. Alland, Darlisha A Williams, 2016 .

Acridine orange fluorescent microscopy is more sensitive than India ink light microscopy in the rapid detection of cryptococcosis among CrAg positive HIV patients

D. Boulware, Darlisha A Williams, Andrew Akampurira, 2017, PloS one.

Evaluation of Fingerstick Cryptococcal Antigen Lateral Flow Assay in HIV-Infected Persons: A Diagnostic Accuracy Study

D. Boulware, Darlisha A Williams, D. Meya, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Epidemiology of meningitis in an HIV-infected Ugandan cohort.

M. Crabtree, D. Boulware, D. Boxrud, 2015, The American journal of tropical medicine and hygiene.

Delta-like 1 protein, vitamin D binding protein and fetuin for detection of Mycobacterium tuberculosis meningitis.

D. Boulware, S. Sreevatsan, Darlisha A Williams, 2018, Biomarkers in medicine.

Cerebrospinal Fluid and Brain Tissue Penetration of Tenofovir, Lamivudine, and Efavirenz in Postmortem Tissues with Cryptococcal Meningitis

D. Boulware, R. Lukande, Darlisha A Williams, 2019, Clinical and translational science.

Diagnostic performance of a multiplex PCR assay for meningitis in an HIV-infected population in Uganda.

D. Boulware, J. Cloud, Darlisha A Williams, 2016, Diagnostic microbiology and infectious disease.

Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial.

D. Boulware, K. Huppler Hullsiek, Darlisha A Williams, 2019, The Lancet. Infectious diseases.

Efficacy of Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis: an open-label dose-ranging study

D. Boulware, K. H. Hullsiek, Darlisha A Williams, 2016, The Lancet. Infectious diseases.

The effect of sertraline on depression and associations with persistent depression in survivors of HIV-related cryptococcal meningitis

S. Lofgren, N. Nakasujja, D. Boulware, 2021, Wellcome Open Research.

Evaluation of the Diagnostic Performance of a Semiquantitative Cryptococcal Antigen Point-of-Care Assay among HIV-Infected Persons with Cryptococcal Meningitis

D. Boulware, Darlisha A Williams, C. Skipper, 2021, Journal of clinical microbiology.

Evaluation of the Dynamiker Cryptococcal Antigen Lateral Flow Assay for the Diagnosis of HIV-Associated Cryptococcosis

D. Boulware, Darlisha A Williams, D. Meya, 2020, Journal of Clinical Microbiology.

Evaluation of a point-of-care immunoassay test kit ‘StrongStep’ for cryptococcal antigen detection

D. Boulware, Darlisha A Williams, Liliane Mukaremera, 2018, PloS one.

Reproducibility of CSF quantitative culture methods for estimating rate of clearance in cryptococcal meningitis.

D. Boulware, J. Dyal, Darlisha A Williams, 2016, Medical mycology.

AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study

Duolao Wang, S. Jaffar, D. Boulware, 2019, BMJ Open.

Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.

D. Boulware, P. Bohjanen, G. Meintjes, 2014, The New England journal of medicine.

Standardized Electrolyte Supplementation and Fluid Management Improves Survival During Amphotericin Therapy for Cryptococcal Meningitis in Resource-Limited Settings

D. Boulware, A. Kambugu, M. Rolfes, 2014, Open forum infectious diseases.

The Effect of Therapeutic Lumbar Punctures on Acute Mortality From Cryptococcal Meningitis

D. Boulware, K. H. Hullsiek, G. Meintjes, 2014, Clinical Infectious Diseases.

Cerebrospinal Fluid Culture Positivity and Clinical Outcomes After Amphotericin-Based Induction Therapy for Cryptococcal Meningitis

D. Boulware, P. Bohjanen, G. Meintjes, 2015, Open forum infectious diseases.

Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin B

D. Boulware, K. H. Hullsiek, R. Mannino, 2020, Antimicrobial Agents and Chemotherapy.

Impact of biological sex on cryptococcal meningitis mortality in Uganda and South Africa.

S. Lofgren, D. Boulware, K. H. Hullsiek, 2021, Medical mycology.

Therapeutic Lumbar Punctures in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management?

D. Boulware, K. H. Hullsiek, Darlisha A Williams, 2022, Open forum infectious diseases.

Brief Report: Effects of Tenofovir and Amphotericin B Deoxycholate Coadministration on Kidney Function in Patients Treated for Cryptococcal Meningitis

D. Boulware, K. H. Hullsiek, Darlisha A Williams, 2016, Journal of acquired immune deficiency syndromes.

Impact of community engagement and social support on the outcomes of HIV-related meningitis clinical trials in a resource-limited setting

L. Haddow, S. Lofgren, D. Boulware, 2020, Research Involvement and Engagement.

Sterile Cerebrospinal Fluid Culture at Cryptococcal Meningitis Diagnosis Is Associated with High Mortality

D. Boulware, K. H. Hullsiek, Darlisha A Williams, 2022, Journal of fungi.

Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal Meningitis.

D. Boulware, K. H. Hullsiek, Darlisha A Williams, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Symptomatic Cryptococcal Antigenemia Presenting as Early Cryptococcal Meningitis With Negative Cerebral Spinal Fluid Analysis.

S. Lofgren, D. Boulware, K. H. Hullsiek, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Tuberculous meningitis diagnosis and outcomes during the Xpert MTB/Rif era: a 6.5-year cohort study in Uganda

D. Boulware, A. Elliott, F. Cresswell, 2018, Wellcome open research.

Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study

D. Boulware, K. H. Hullsiek, C. Denkinger, 2018, The Lancet. Infectious diseases.

Evolving Failures in the Delivery of Human Immunodeficiency Virus Care: Lessons From a Ugandan Meningitis Cohort 2006–2016

D. Boulware, M. Roediger, K. H. Hullsiek, 2017, Open forum infectious diseases.

Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis

D. Boulware, K. H. Hullsiek, Darlisha A Williams, 2019, Open forum infectious diseases.

CSF early fungicidal activity as a surrogate endpoint for cryptococcal meningitis survival in clinical trials.

D. Boulware, K. H. Hullsiek, G. Meintjes, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Early ART After Cryptococcal Meningitis Is Associated With Cerebrospinal Fluid Pleocytosis and Macrophage Activation in a Multisite Randomized Trial

D. Boulware, K. H. Hullsiek, G. Meintjes, 2015, The Journal of infectious diseases.

HIV-Associated Cryptococcal Meningitis Occurring at Relatively Higher CD4 Counts

S. Lofgren, D. Boulware, K. H. Hullsiek, 2018, The Journal of infectious diseases.

Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts

N. Nakasujja, D. Boulware, P. Bohjanen, 2017, BMC Neurology.

A secondary analysis of depression outcomes from a randomized controlled trial of adjunctive sertraline for HIV-associated cryptococcal meningitis

S. Lofgren, N. Nakasujja, D. Boulware, 2022, Wellcome Open Research.

Tuberculosis in HIV-Associated Cryptococcal Meningitis is Associated with an Increased Risk of Death

D. Boulware, K. H. Hullsiek, F. Cresswell, 2020, Journal of clinical medicine.

Differences in Immunologic Factors Among Patients Presenting with Altered Mental Status During Cryptococcal Meningitis

S. Lofgren, D. Boulware, K. H. Hullsiek, 2017, The Journal of infectious diseases.

Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial

J. Balko, S. Lofgren, D. Boulware, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial

J. Balko, S. Lofgren, D. Boulware, 2020, medRxiv.

Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient Trials

S. Lofgren, D. Boulware, K. H. Hullsiek, 2021, Open forum infectious diseases.

Severe Babesiosis in Immunocompetent Man, Spain, 2011

D. Boulware, G. Meintjes, J. Scriven, 2018 .

Symptomatic cryptococcal antigenemia presenting as early cryptococcal meningitis with negative CSF analysis

D. Boulware, K. H. Hullsiek, F. Cresswell, 2019 .

Human Immune Response Varies by the Degree of Relative Cryptococcal Antigen Shedding

D. Boulware, Tami R. McDonald, G. Meintjes, 2015, Open forum infectious diseases.

Tristetraprolin Mediates Interferon-γ mRNA Decay*

P. Blackshear, Rachel L. Ogilvie, P. Bohjanen, 2009, Journal of Biological Chemistry.

Role of CXCR4 in Cell-Cell Fusion and Infection of Monocyte-Derived Macrophages by Primary Human Immunodeficiency Virus Type 1 (HIV-1) Strains: Two Distinct Mechanisms of HIV-1 Dual Tropism

E. De Clercq, D. Kolson, I. Frank, 1999, Journal of Virology.

Coordinate stabilization of growth-regulatory transcripts in T cell malignancies.

C. Reilly, A. Raghavan, P. Bohjanen, 2005, Genomics.

COVID-19 and the HIV care continuum in Uganda: minimising collateral damage

F. Cresswell, Darlisha A Williams, D. Meya, 2020, AAS Open Research.

Antiretroviral Therapy Down-Regulates Innate Antiviral Response Genes in Patients With AIDS in Sub-Saharan Africa

D. Boulware, P. Bohjanen, A. Kambugu, 2010, Journal of acquired immune deficiency syndromes.

Effi cacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis : an open-label dose-ranging study

D. Boulware, K. H. Hullsiek, Darlisha A Williams, 2016 .

Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19

S. Lofgren, D. Boulware, K. H. Hullsiek, 2020, medRxiv.

Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19

S. Lofgren, D. Boulware, K. H. Hullsiek, 2020, Annals of Internal Medicine.

Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial.

Takudzwa J Mtisi, S. Jaffar, D. Boulware, 2022, The Lancet. Global health.

Association of Hyponatremia on Mortality in Cryptococcal Meningitis: A Prospective Cohort

D. Boulware, K. H. Hullsiek, Darlisha A Williams, 2022, Open forum infectious diseases.

Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based

Duolao Wang, S. Jaffar, D. Boulware, 2019 .

Lessons Learned From Conducting Internet-Based Randomized Clinical Trials During a Global Pandemic

S. Lofgren, D. Boulware, K. H. Hullsiek, 2020, Open forum infectious diseases.

Correlation between Blood and CSF Compartment Cytokines and Chemokines in Subjects with Cryptococcal Meningitis

D. Boulware, K. H. Hullsiek, G. Meintjes, 2020, Mediators of inflammation.

Improved diagnostic sensitivity for tuberculous meningitis with Xpert(®) MTB/RIF of centrifuged CSF.

D. Alland, D. Boulware, D. Williams, 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Performance of Lipoarabinomannan Assay using Cerebrospinal fluid for the diagnosis of Tuberculous meningitis among HIV patients

D. Boulware, F. Cresswell, Darlisha A Williams, 2019, Wellcome open research.

HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation.

R. Doms, E. De Clercq, B. Freedman, 2000, Proceedings of the National Academy of Sciences of the United States of America.

HIV-1 gp 120 and chemokines activate ion channels in primary macrophages through CCR 5 and CXCR 4 stimulation

R. Doms, B. Freedman, C. Mcmanus, 2000 .

Can improved diagnostics reduce mortality from Tuberculous meningitis? Findings from a 6.5-year cohort in Uganda

D. Boulware, F. Cresswell, Darlisha A Williams, 2018, Wellcome Open Research.

The Effect of Therapeutic Lumbar Punctures on Acute Mortality From Cryptococcal Meningitis

D. Boulware, K. H. Hullsiek, G. Meintjes, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial.

D. Boulware, K. H. Hullsiek, P. Williamson, 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prognostic implications of baseline anaemia and changes in haemoglobin concentrations with amphotericin B therapy for cryptococcal meningitis

D. Boulware, K. H. Hullsiek, D. Williams, 2017, HIV medicine.

Antiretroviral Therapy Down-Regulates Innate Antiviral Response Genes in Patients With AIDS in Sub-Saharan Africa

D. Boulware, P. Bohjanen, A. Kambugu, 2010, Journal of acquired immune deficiency syndromes.

Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin B

D. Boulware, K. H. Hullsiek, R. Mannino, 2020, Antimicrobial Agents and Chemotherapy.

869. Oral Encochleated Amphotericin B for Cryptococcal Meningitis: a Phase II Randomized Trial

D. Boulware, K. H. Hullsiek, Darlisha A Williams, 2022, Open Forum Infectious Diseases.